Transcatheter Tricuspid Valve-in-Valve Implantation With a Novel Balloon Expandable Myval THV
Annals of Thoracic Surgery, cilt.112, sa.6, 2021 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 112 Sayı: 6
- Basım Tarihi: 2021
- Doi Numarası: 10.1016/j.athoracsur.2021.03.014
- Dergi Adı: Annals of Thoracic Surgery
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
- Ankara Yıldırım Beyazıt Üniversitesi Adresli: Evet
Özet
© 2021 The Society of Thoracic SurgeonsThe transcatheter tricuspid valve-in-valve implantation has not yet been clarified, and several case series have documented results in patients with tricuspid bioprosthetic valve degeneration who underwent transcatheter implantation of Edwards SAPIEN XT and SAPIEN 3 (Edwards Lifesciences, Irvine, CA) and Medtronic (Minneapolis, MN) valves. Here, we present the case of a patient with severe bioprosthetic tricuspid valve stenosis who was successfully treated with the transfemoral route through the 29-mm novel balloon expandable Myval transcatheter heart valve (Meril Life Sciences Pvt Ltd, Vapi, Gujarat, India) system.